-
Jul 22, 2025NHP Acute Hemorrhage Model: A Crucial Tool For Accelerating Novel Hematology ...Explore how Prisys Biotech's non-human primate (NHP) acute hemorrhage model provides a high-fidelity platform for evaluating novel therapies like hemoglobin-based oxygen carrier... -
Jul 18, 2025Pruritus Research: Prisys Biotech’s IL-31-Induced NHP Model For Evaluating An...Prisys Biotech offers a translational NHP pruritus model induced by IL-31. Leveraging an advanced AI behavioral analysis system, we provide objective quantification of scratchin... -
Jul 10, 2025A Guide To Anti-Drug Antibody (ADA) AssessmentExplore ADA formation, risk factors, impact on PK/ADME, and advanced preclinical assessment strategies, including the TDAR assay offered by Prisys Biotech. -
Jul 08, 2025Respiratory Therapies: Prisys Biotech's Integrated NHP Platform For Preclinic...Explore Prisys Biotech's comprehensive preclinical platform for respiratory diseases. Discover advanced NHP models, precision pulmonary drug delivery, BALF analysis, and PFTs de... -
Jul 04, 2025NHP Pain Models: Accelerating Analgesic Drug Development At Prisys BiotechExplore Prisys Biotech's validated non-human primate (NHP) pain models for acute, chronic, and neuropathic pain. Our advanced assessment technologies, including AI-driven behavi... -
Aug 20, 2025Meet Prisys Biotech At Upcoming EU Roadshow: September 2025Prisys Biotech is coming to Germany, France, Switzerland, Belgium, Denmark, and the Netherlands this September! Let’s explore how our advanced non-human primate (NHP) research p... -
Jun 30, 2025NHP Model Platforms To Support Drug Development in Complex DiseasesPrisys Biotech, specializing in Non-Human Primate (NHP) models, has recently expanded its translational research platforms to better support drug development in dermatology, neu... -
Jun 19, 2025Prisys Biotech – 2025 Mid-Year ReviewPrisys Key R&D Milestones in Q1-Q2, 2025 Translational NHP models of 'Atopic March': Atopic Dermatitis, Asthma… AI-based NHP 'scratch-counts' for the evaluation of anti-prurit...
-
Jun 26, 2025Key Considerations For Dosing Volume, PH, And Formulation in Animal ModelsLearn essential considerations for preclinical pharmacokinetic (PK) studies, including recommended dosing volumes, pH ranges, and formulation strategies for different animal spe... -
Jun 17, 2025Engineered Exosomes: Revolutionizing Drug Delivery For CNS Disorders – Precli...Explore the potential of engineered exosomes as advanced drug delivery vehicles for CNS diseases. Learn about their advantages, targeting strategies, and the critical role of pr... -
Jun 13, 2025Guiding Principles For Animal Species Selection in Nucleic Acid Drug Toxicolo...Explore key considerations for selecting appropriate animal species in non-clinical toxicology studies for nucleic acid drugs, focusing on on-target and off-target toxicity asse... -
Jun 10, 2025Prisys Biotech’s Advanced DSA And IMRI For Hematological, Vascular, And Renal...Discover how Prisys Biotech's cutting-edge Digital Subtraction Angiography (DSA) and intraoperative MRI (iMRI) technologies, combined with expert teams, are advancing preclinica...
